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Abstract: Background and Aim: Malnutrition represents a serious health 
care threat, as it increases morbidity, mortality and health care cost. 
The effective screening and treatment with enteral (EN) or parenteral 
(PN) nutrition are the key elements of the policy called Optimal 
Nutrition Care for All (ONCA). The study tried to analyze the  impact of 
the state's economy on the implementation of EN and PN to define its role 
in ONCA.  
Material and Methods: an international survey in twenty two European 
countries was performed between January and December 2014. An electronic 
questionnaire was distributed to 22 representatives of clinical nutrition 
(PEN) societies. The questionnaire comprised questions regarding country 
economy, reimbursement, education and the use EN and PN. Return rate was 
90.1% (n=20) 
Results: EN and PN were used in all countries surveyed (100%), but to 
different extent. The country's income significantly influenced the 
reimbursement for EN and PN (p<0.05). It was also associated with the 
overall use of tube feeding and PN (p=0.05), but not with the use of oral 
nutritional supplements (p=0.165). The use of both, EN and PN at 
hospitals was not depended on the economy (p>0.05). Education was 
actively carried out in all countries, however the teaching at the pre-
graduate level was the least widespread, and also correlated with the 
country income (p=0.042).  
Conclusions: Results indicated that economic situation influences all 
aspects of ONCA, including education and treatment. The reimbursement for 
EN and PN seemed to be the key factor of effective campaign against 
malnutrition. 
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ABSTRACT 53 
Background and Aim: Malnutrition represents a serious health care threat, as it increases 54 
morbidity, mortality and health care cost. The effective screening and treatment with enteral 55 
(EN) or parenteral (PN) nutrition are the key elements of the policy called Optimal Nutrition 56 
Care for All (ONCA). The study tried to analyze the  impact of the state’s economy on the 57 
implementation of EN and PN to define its role in ONCA.  58 
Material and Methods: an international survey in twenty two European countries was 59 
performed between January and December 2014. An electronic questionnaire was distributed 60 
to 22 representatives of clinical nutrition (PEN) societies. The questionnaire comprised 61 
questions regarding country economy, reimbursement, education and the use EN and PN. 62 
Return rate was 90.1% (n=20) 63 
Results: EN and PN were used in all countries surveyed (100%), but to different extent. The 64 
country’s income significantly influenced the reimbursement for EN and PN (p<0.05). It was 65 
also associated with the overall use of tube feeding and PN (p=0.05), but not with the use of 66 
oral nutritional supplements (p=0.165). The use of both, EN and PN at hospitals was not 67 
depended on the economy (p>0.05). Education was actively carried out in all countries, 68 
however the teaching at the pre-graduate level was the least widespread, and also correlated 69 
with the country income (p=0.042).  70 
Conclusions: Results indicated that economic situation influences all aspects of ONCA, 71 
including education and treatment. The reimbursement for EN and PN seemed to be the key 72 
factor of effective campaign against malnutrition. 73 
 74 
 75 
 76 
 77 
INTRODUCTION 78 
Malnutrition (also: disease-related malnutrition, DRM) is undoubtedly a serious public health 79 
issue worldwide.[1,2] It increases morbidity, mortality, the length of hospital stay, and health-80 
care costs.[1,2,3] The prevalence of malnutrition differs depending on the patient’s 81 
population, country, clinical settings, yet it can be diagnosed in 7-16% of outpatients and in 82 
20-60% patients at admission to hospital.[3-8] The criteria for that diagnostic varied 83 
significantly among authors, but in most of cases the body mass index (BMI) of < 18.5 kg/m
2
 84 
and unintentional body weight loss >10% last 3-6 months, were applied. [3-8] Unfortunately, 85 
the problem of malnutrition is often unnoticed, undiagnosed or untreated, while it generates 86 
more costs than overnutrition or obesity, according to British Society for Enteral and 87 
Parenteral Nutrition (BAPEN).[9] 88 
The European Society for Clinical Nutrition and Metabolism (ESPEN) recognized DRM as a 89 
grave problem more than thirty years ago. Since then, the society has undertaken many 90 
actions to change this situation. At the beginning, those activities were called the Fight 91 
Against Malnutrition (FAM).[1] In 2014 FAM became a part of a campaign called Optimal 92 
Nutrition Care for All (ONCA).[10] ONCA’s aim is to facilitate screening for risk of disease-93 
related malnutrition/undernutrition and nutritional care implementation across Europe.[10] 94 
ONCA includes, among others, the worldwide ‘NutritionDay’ survey, many local and 95 
international events (including ONCA conferences in Brussels, Prague, Vienna, Warsaw and 96 
Zagreb), scientific and research grants, scientific and educational symposia, workshops and 97 
trainings. This activity is administered by European Nutrition for Health Alliance (ENHS), an 98 
association of stakeholders, in which ESPEN is the strategic partner. Therefore, it is possible 99 
to perform all actions in a close cooperation with national scientific societies for enteral and 100 
parenteral nutrition (or clinical nutrition) societies, so-called ‘PEN’ societies. Those activities 101 
increased awareness, improved screening, amplified the use of enteral (EN) and parenteral 102 
nutrition (PN), representing two types of clinical nutrition support (CN), hence, improved the 103 
situation. Results differed, however, among countries. The question what are the key elements 104 
of efficient ONCA emerged and remained unanswered. Therefore, the purpose of the study 105 
was to answer that query by assessing the situation in European countries. Following aspects 106 
were analyzed: the presence of the reimbursement for each type of clinical nutrition (CN); the 107 
level of education for CN and the real use of EN and PN in various short- and long term 108 
settings. 109 
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 112 
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 117 
 118 
 119 
 120 
 121 
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 129 
 130 
METHODS 131 
An European survey was performed using an electronic questionnaire [Table 1]. The whole 132 
project was accomplished within 12 months, between January and December 2014, due to 133 
questionnaires distribution, local surveys and further data collecting. The questionnaire was 134 
circulated to representatives of twenty-two PEN societies. Participants were supposed to 135 
answer all questions, including the prevalence of malnutrition, using recent, already collected, 136 
data or new survey performed for the purpose of the study. The diagnostic criteria for 137 
malnutrition were (either of the following): 138 
- body mass index (BMI) of < 18.5 kg/m2  139 
- and unintentional body weight loss >10% last 3-6 months. 140 
For the purpose of financial analysis, all participating countries were categorized by their 141 
economic status according to the World Bank criteria for national income [9], and by tertiles 142 
of the average health care expenditure per head for 2012 [9]. 143 
On the basis of the national income, three categories were selected: 144 
a. lower middle income countries: Ukraine 145 
b. upper middle income countries: Serbia, Turkey 146 
c. high income: Croatia, Czech Republic, Estonia, Finland, France, Germany, Greece, 147 
Ireland, Italy, Latvia, Netherlands, Norway, Poland, Russia, Spain, Switzerland, UK 148 
On the basis of annual healthcare expenditure, three tertiles were named: 149 
a. 1st tertile (293 - 908 US Dollars/per person): Croatia, Latvia, Poland, Russia, Serbia, 150 
Turkey, Ukraine 151 
b. 2nd tertile (1010-3708 USD/per person): Czech Republic, Estonia, Greece, Ireland, 152 
Italy, Spain, UK 153 
c. 3rd tertile (4232-9055 USD/per person): Finland, France, Germany, Netherlands,  154 
Norway, Switzerland 155 
The following parameters were analyzed for each participating country: 156 
- prevalence of malnutrition 157 
- institution responsible for health care regulations 158 
- presence and type of insurance company (public/ private/ both) 159 
- use of EN and PN at various settings (hospitals, home, chronic care facilities) 160 
- presence of the reimbursement for EN and PN  161 
- presence and type of education in the field of CN 162 
The term ‘hospital settings’ referred to all in-patients, ‘home’ to all out-patients staying at 163 
home along/ with family/ other care-givers, but without any additional chronic care provided 164 
at his/her household level, chronic care and palliative care centers referred to all patients 165 
staying outside home, at long term care facilities, due to untreatable cancer (the latter) or any 166 
chronic condition, other than cancer (the first).  167 
 168 
Statistical Analysis 169 
The statistical analysis was performed using the SPSS v.19 (SPSS Inc., Chicago, IL) software 170 
package. Because in every analysis the expected frequency was less than 5 in more than 20% 171 
of cells, the Fisher test was used for the analyses of categorical variables. The prevalence of 172 
malnutrition, and the proportion of patients with indicators for EN or PN who receive 173 
treatment were considered as continuous variables. As the sample size was relatively small, 174 
the normal distribution was not tested due to low power to reject a null hypothesis (assuming 175 
equivalence to normal distribution). Consequently, the U-Mann-Whitney test for two-group 176 
and the Kruskal-Wallis test for three-group comparisons were used. To show more detailed 177 
descriptive information, means, standard deviation, medians, interquartile range, minimal and 178 
maximal values were provided. A p-value <0.05 was accepted as being statistically 179 
significant.  180 
 181 
RESULTS 182 
Twenty answered questionnaires were returned (the response rate was 90.1%), and analyzed. 183 
Insurance companies operated as health care financiers in all twenty participating countries 184 
(100%). There were only private institutions in Serbia, Ukraine and the United Kingdom 185 
(UK), while in Croatia, France and Poland health care expenses were covered by the state-186 
funded and state-governed entity. In the other fourteen countries both private and state 187 
insurance companies were present.  188 
The Ministry of Health (or its local equivalent) was the institution responsible for forming 189 
health policy in all countries (100%). Additionally, Interterritorial Council and Regional 190 
Governments contributed to that process in Spain, while the insurance companies participated 191 
in the process in Croatia, Finland, Ireland and Poland. In Estonia the opinion of medical 192 
societies was always formally taken into account, while in Norway the direct input of the 193 
National Assembly was important.  194 
Enteral (EN) and parenteral nutrition (PN) were used in all European countries (100%), but to 195 
different extend. This relation was clear as far as the place of care was considered (hospital, 196 
home, long term facility). EN and PN were available to all patients in all countries at the 197 
hospital settings. EN and PN were not used on a regular basis in chronic care facilities in 198 
Croatia, Latvia and Ukraine, at home in Latvia and Russia, nor at palliative cancer care 199 
centers in Croatia, Latvia, Russia and Serbia. The UK’s situation regarding palliative care 200 
nutrition is much more complicated as intravenous infusions are often not permitted in 201 
palliative care homes, although the use of PN for cancer-related intestinal failure has been one 202 
of the most quickly growing patient groups.  203 
A general overview shows that the use of EN and PN in European countries fails to correlate 204 
closely with the income of the country, as presented in Table 2. The level of per capita 205 
healthcare expenditure and use of clinical nutrition were not correlated, for all countries there 206 
was no statistically significant difference (p>0.05) 207 
The use of clinical nutrition in chronic care centers, in palliative centers, and at home, seemed 208 
to be associated with the country’s overall income, but those associations were not 209 
statistically significant (p=0.302, p=0.302 and p=0.088, respectively).  210 
Analysis based on the influence of health care expenditure per capita showed no statistical 211 
differences as far as the use of EN (p=1.000) was concerned, but significant differences for 212 
PN. The latter was observed to be of a higher prevalence at home and chronic care facilities in 213 
countries from the 2
nd
 and 3
rd
 tertiles (p=0.018). 214 
The level of the country’s income was associated with reimbursement for EN and PN, as 215 
presented in Table 3.  The reimbursement was crucial as far as the use of tube feeding and 216 
intravenous nutrition were considered (p=0.05), but did not matter in the case of oral 217 
nutritional supplements (p=0.165, Table 4). Similar observations were made for the 218 
differences in use of PN in chronic settings and in the patient’s home (p=0.001 and p=0.014, 219 
respectively) 220 
If EN and/or PN was not reimbursed, all costs were covered by patient or his/her family.  221 
The prevalence of malnutrition, as identified by our respondents, is significantly and 222 
negatively associated with national income (p=0.038). The data for the prevalence were 223 
collected by representatives of local PEN societies. 224 
The greater use of CN across categories of income level was also associated with a lower 225 
proportion of patients with indications for EN and PN, but the numbers here are small and the 226 
results are not statistically significant (Table 5). The reimbursement proved to be a strong 227 
predictor for the use of enteral tube feeding, and for all types of CN, in chronic care facilities 228 
(p=0.001 for both), as well as for the use of parenteral nutrition, and all types of CN, at home 229 
(p=0.014 for both) (Table 7). 230 
The proportion of patients with indications for CN to those who actually received treatment 231 
was also calculated. Our analyses confirm positive links for both EN and PN, but there are 232 
countries (Ukraine for EN, Poland for EN and PN, Czech Republic for EN and PN, and 233 
Greece for PN) with relatively low amounts of money but high proportions of treated patients, 234 
and, on the other hand, countries (France and Germany, both for EN and PN) with more 235 
money available but lower proportions of treated patients (Figure 1 and Figure 2) 236 
Local PEN societies representative collected the data on education. Trainings for clinical 237 
nutrition was present in all twenty countries participating in the study (100%). Most 238 
frequently these activities were organized by national PEN societies as local trainings (17 239 
countries [85%]), quite common were also postgraduate trainings and ESPEN LLL programs 240 
(16 [80%] and 12 [60%] countries respectively). Investigation of the relationship between 241 
different types of medical training and the average per capita healthcare expenditure showed 242 
little linkage with postgraduate, ESPEN LLL or local PEN society training. The prevalence of 243 
undergraduate training was clearly related to the country's health care expenditure showing a 244 
significant increase across categories of financial commitment (p=0.042) (Table 6). 245 
No relation between the number of educational activities and the factual use of CN was 246 
observed. (p>0.05) 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
DISCUSSION 256 
Malnutrition represent a serious health care thread as it increases morbidity, mortality and 257 
health care cost for all age groups. [1,2]  A new Croatian study showed that the total cost of 258 
adult malnutrition for selected diagnoses was €97.35 million per year, accounting for 3.38% 259 
of the total Croatian national health care budget, and the average cost per patient was 260 
estimated at €1640.48. [12] The largest share was used for medications (43%), followed by 261 
34% for hospitalization, 13% for community health nursing, while PN and EN costs 262 
contributed with 6% and 1% respectively.[12] Malnutrition is widespread - recent European 263 
survey showed that 57.4% of Estonian, 39.4% of Turkish, 32.8% Greek, 21.9% Polish and 264 
14.2% of Lithuanian patients were diagnosed with malnutrition [13] Moreover, severe 265 
malnutrition was reported in 19.7% of Turkish patients, and in 9.9% of Polish and Greek 266 
individuals (9.4%).[13]  267 
Therefore, actions like FAM, are of the utmost importance. The implementation of EN and 268 
PN, which are, along with screening, key elements for the efficient FAM, vary among 269 
countries. The same study showed that they could be influenced by the political situation, 270 
economy as well as the activity of the national PEN societies in term of raising the awareness, 271 
education, cooperation with funding and policy-making authorities. The latter seemed to be 272 
affected by the economy as well. 273 
The factual associations among education, economy, reimbursement and the utilization of EN 274 
and PN have, however, never been thoroughly analyzed. Therefore, the following study was 275 
supposed to address those ambiguities.  276 
Some of results were really encouraging: both EN and PN are used in all of the European 277 
countries surveyed, apparently independently of the income of the country. They are, 278 
however, mostly available to patients at hospital settings, and often unavailable to those at 279 
chronic care facilities or at home. National income did not appear to influence that situation 280 
directly, but greatly influenced reimbursement both for EN and PN, which seem to have 281 
important effects on their utilization.  Oral nutritional supplements (ONS) were the only 282 
treatment method to prove otherwise. Education for clinical nutrition was present in all 283 
participating countries (100%). Those included, however, mostly postgraduate activities, often 284 
held by the national PEN or ESPEN, not by the local institutions.  Pregraduate education was 285 
much less frequent, and that fact was inversely related to country income. The level of 286 
education did not influence the administration of neither EN nor PN.  287 
To our knowledge this is the first survey on the educational and economic aspects of the fight 288 
against malnutrition. Authors are aware of the limitations of the study, particularly the 289 
dependence on local PEN’s representatives regarding the provision of data. It is important, 290 
however, to emphasize that there is no other method of collecting such circuitous data. 291 
Undoubtedly, the study offered a lot of new data, which provided a new insight into the 292 
treatment of malnutrition.  293 
Results indicated unequivocally that economic situation influences all aspects of actions 294 
against malnutrition, including education and treatment. The reimbursement for EN and PN 295 
seemed also to be of a vital role for those activities. 296 
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ABSTRACT 53 
Background and Aim: Malnutrition represents a serious health care threat, as it increases 54 
morbidity, mortality and health care cost. The effective screening and treatment with enteral 55 
(EN) or parenteral (PN) nutrition are the key elements of the policy called Optimal Nutrition 56 
Care for All (ONCA). The study tried to analyze the  impact of the state’s economy on the 57 
implementation of EN and PN to define its role in ONCA.  58 
Material and Methods: an international survey in twenty two European countries was 59 
performed between January and December 2014. An electronic questionnaire was distributed 60 
to 22 representatives of clinical nutrition (PEN) societies. The questionnaire comprised 61 
questions regarding country economy, reimbursement, education and the use EN and PN. 62 
Return rate was 90.1% (n=20) 63 
Results: EN and PN were used in all countries surveyed (100%), but to different extent. The 64 
country’s income significantly influenced the reimbursement for EN and PN (p<0.05). It was 65 
also associated with the overall use of tube feeding and PN (p=0.05), but not with the use of 66 
oral nutritional supplements (p=0.165). The use of both, EN and PN at hospitals was not 67 
depended on the economy (p>0.05). Education was actively carried out in all countries, 68 
however the teaching at the pre-graduate level was the least widespread, and also correlated 69 
with the country income (p=0.042).  70 
Conclusions: Results indicated that economic situation influences all aspects of ONCA, 71 
including education and treatment. The reimbursement for EN and PN seemed to be the key 72 
factor of effective campaign against malnutrition. 73 
 74 
 75 
 76 
 77 
INTRODUCTION 78 
Malnutrition (also: disease-related malnutrition, DRM) is undoubtedly a serious public health 79 
issue worldwide.[1,2] It increases morbidity, mortality, the length of hospital stay, and health-80 
care costs.[1,2,3] The prevalence of malnutrition differs depending on the patient’s 81 
population, country, clinical settings, yet it can be diagnosed in 7-16% of outpatients and in 82 
20-60% patients at admission to hospital.[3-8] The criteria for that diagnostic varied 83 
significantly among authors, but in most of cases the body mass index (BMI) of < 18.5 kg/m
2
 84 
and unintentional body weight loss >10% last 3-6 months, were applied. [3-8] Unfortunately, 85 
the problem of malnutrition is often unnoticed, undiagnosed or untreated, while it generates 86 
more costs than overnutrition or obesity, according to British Society for Enteral and 87 
Parenteral Nutrition (BAPEN).[9] 88 
The European Society for Clinical Nutrition and Metabolism (ESPEN) recognized DRM as a 89 
grave problem more than thirty years ago. Since then, the society has undertaken many 90 
actions to change this situation. At the beginning, those activities were called the Fight 91 
Against Malnutrition (FAM).[1] In 2014 FAM became a part of a campaign called Optimal 92 
Nutrition Care for All (ONCA).[10] ONCA’s aim is to facilitate screening for risk of disease-93 
related malnutrition/undernutrition and nutritional care implementation across Europe.[10] 94 
ONCA includes, among others, the worldwide ‘NutritionDay’ survey, many local and 95 
international events (including ONCA conferences in Brussels, Prague, Vienna, Warsaw and 96 
Zagreb), scientific and research grants, scientific and educational symposia, workshops and 97 
trainings. This activity is administered by European Nutrition for Health Alliance (ENHS), an 98 
association of stakeholders, in which ESPEN is the strategic partner. Therefore, it is possible 99 
to perform all actions in a close cooperation with national scientific societies for enteral and 100 
parenteral nutrition (or clinical nutrition) societies, so-called ‘PEN’ societies. Those activities 101 
increased awareness, improved screening, amplified the use of enteral (EN) and parenteral 102 
nutrition (PN), representing two types of clinical nutrition support (CN), hence, improved the 103 
situation. Results differed, however, among countries. The question what are the key elements 104 
of efficient ONCA emerged and remained unanswered. Therefore, the purpose of the study 105 
was to answer that query by assessing the situation in European countries. Following aspects 106 
were analyzed: the presence of the reimbursement for each type of clinical nutrition (CN); the 107 
level of education for CN and the real use of EN and PN in various short- and long term 108 
settings. 109 
 110 
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 112 
 113 
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 120 
 121 
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 124 
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 128 
 129 
 130 
METHODS 131 
An European survey was performed using an electronic questionnaire [Table 1]. The whole 132 
project was accomplished within 12 months, between January and December 2014, due to 133 
questionnaires distribution, local surveys and further data collecting. The questionnaire was 134 
circulated to representatives of twenty-two PEN societies. Participants were supposed to 135 
answer all questions, including the prevalence of malnutrition, using recent, already collected, 136 
data or new survey performed for the purpose of the study. The diagnostic criteria for 137 
malnutrition were (either of the following): 138 
- body mass index (BMI) of < 18.5 kg/m2  139 
- and unintentional body weight loss >10% last 3-6 months. 140 
For the purpose of financial analysis, all participating countries were categorized by their 141 
economic status according to the World Bank criteria for national income [9], and by tertiles 142 
of the average health care expenditure per head for 2012 [9]. 143 
On the basis of the national income, three categories were selected: 144 
a. lower middle income countries: Ukraine 145 
b. upper middle income countries: Serbia, Turkey 146 
c. high income: Croatia, Czech Republic, Estonia, Finland, France, Germany, Greece, 147 
Ireland, Italy, Latvia, Netherlands, Norway, Poland, Russia, Spain, Switzerland, UK 148 
On the basis of annual healthcare expenditure, three tertiles were named: 149 
a. 1st tertile (293 - 908 US Dollars/per person): Croatia, Latvia, Poland, Russia, Serbia, 150 
Turkey, Ukraine 151 
b. 2nd tertile (1010-3708 USD/per person): Czech Republic, Estonia, Greece, Ireland, 152 
Italy, Spain, UK 153 
c. 3rd tertile (4232-9055 USD/per person): Finland, France, Germany, Netherlands,  154 
Norway, Switzerland 155 
The following parameters were analyzed for each participating country: 156 
- prevalence of malnutrition 157 
- institution responsible for health care regulations 158 
- presence and type of insurance company (public/ private/ both) 159 
- use of EN and PN at various settings (hospitals, home, chronic care facilities) 160 
- presence of the reimbursement for EN and PN  161 
- presence and type of education in the field of CN 162 
The term ‘hospital settings’ referred to all in-patients, ‘home’ to all out-patients staying at 163 
home along/ with family/ other care-givers, but without any additional chronic care provided 164 
at his/her household level, chronic care and palliative care centers referred to all patients 165 
staying outside home, at long term care facilities, due to untreatable cancer (the latter) or any 166 
chronic condition, other than cancer (the first).  167 
 168 
Statistical Analysis 169 
The statistical analysis was performed using the SPSS v.19 (SPSS Inc., Chicago, IL) software 170 
package. Because in every analysis the expected frequency was less than 5 in more than 20% 171 
of cells, the Fisher test was used for the analyses of categorical variables. The prevalence of 172 
malnutrition, and the proportion of patients with indicators for EN or PN who receive 173 
treatment were considered as continuous variables. As the sample size was relatively small, 174 
the normal distribution was not tested due to low power to reject a null hypothesis (assuming 175 
equivalence to normal distribution). Consequently, the U-Mann-Whitney test for two-group 176 
and the Kruskal-Wallis test for three-group comparisons were used. To show more detailed 177 
descriptive information, means, standard deviation, medians, interquartile range, minimal and 178 
maximal values were provided. A p-value <0.05 was accepted as being statistically 179 
significant.  180 
 181 
RESULTS 182 
Twenty answered questionnaires were returned (the response rate was 90.1%), and analyzed. 183 
Insurance companies operated as health care financiers in all twenty participating countries 184 
(100%). There were only private institutions in Serbia, Ukraine and the United Kingdom 185 
(UK), while in Croatia, France and Poland health care expenses were covered by the state-186 
funded and state-governed entity. In the other fourteen countries both private and state 187 
insurance companies were present.  188 
The Ministry of Health (or its local equivalent) was the institution responsible for forming 189 
health policy in all countries (100%). Additionally, Interterritorial Council and Regional 190 
Governments contributed to that process in Spain, while the insurance companies participated 191 
in the process in Croatia, Finland, Ireland and Poland. In Estonia the opinion of medical 192 
societies was always formally taken into account, while in Norway the direct input of the 193 
National Assembly was important.  194 
Enteral (EN) and parenteral nutrition (PN) were used in all European countries (100%), but to 195 
different extend. This relation was clear as far as the place of care was considered (hospital, 196 
home, long term facility). EN and PN were available to all patients in all countries at the 197 
hospital settings. EN and PN were not used on a regular basis in chronic care facilities in 198 
Croatia, Latvia and Ukraine, at home in Latvia and Russia, nor at palliative cancer care 199 
centers in Croatia, Latvia, Russia and Serbia. The UK’s situation regarding palliative care 200 
nutrition is much more complicated as intravenous infusions are often not permitted in 201 
palliative care homes, although the use of PN for cancer-related intestinal failure has been one 202 
of the most quickly growing patient groups.  203 
A general overview shows that the use of EN and PN in European countries fails to correlate 204 
closely with the income of the country, as presented in Table 2. The level of per capita 205 
healthcare expenditure and use of clinical nutrition were not correlated, for all countries there 206 
was no statistically significant difference (p>0.05) 207 
The use of clinical nutrition in chronic care centers, in palliative centers, and at home, seemed 208 
to be associated with the country’s overall income, but those associations were not 209 
statistically significant (p=0.302, p=0.302 and p=0.088, respectively).  210 
Analysis based on the influence of health care expenditure per capita showed no statistical 211 
differences as far as the use of EN (p=1.000) was concerned, but significant differences for 212 
PN. The latter was observed to be of a higher prevalence at home and chronic care facilities in 213 
countries from the 2
nd
 and 3
rd
 tertiles (p=0.018). 214 
The level of the country’s income was associated with reimbursement for EN and PN, as 215 
presented in Table 3.  The reimbursement was crucial as far as the use of tube feeding and 216 
intravenous nutrition were considered (p=0.05), but did not matter in the case of oral 217 
nutritional supplements (p=0.165, Table 4). Similar observations were made for the 218 
differences in use of PN in chronic settings and in the patient’s home (p=0.001 and p=0.014, 219 
respectively) 220 
If EN and/or PN was not reimbursed, all costs were covered by patient or his/her family.  221 
The prevalence of malnutrition, as identified by our respondents, is significantly and 222 
negatively associated with national income (p=0.038). The data for the prevalence were 223 
collected by representatives of local PEN societies. 224 
The greater use of CN across categories of income level was also associated with a lower 225 
proportion of patients with indications for EN and PN, but the numbers here are small and the 226 
results are not statistically significant (Table 5). The reimbursement proved to be a strong 227 
predictor for the use of enteral tube feeding, and for all types of CN, in chronic care facilities 228 
(p=0.001 for both), as well as for the use of parenteral nutrition, and all types of CN, at home 229 
(p=0.014 for both) (Table 7). 230 
The proportion of patients with indications for CN to those who actually received treatment 231 
was also calculated. Our analyses confirm positive links for both EN and PN, but there are 232 
countries (Ukraine for EN, Poland for EN and PN, Czech Republic for EN and PN, and 233 
Greece for PN) with relatively low amounts of money but high proportions of treated patients, 234 
and, on the other hand, countries (France and Germany, both for EN and PN) with more 235 
money available but lower proportions of treated patients (Figure 1 and Figure 2) 236 
Local PEN societies representative collected the data on education. Trainings for clinical 237 
nutrition was present in all twenty countries participating in the study (100%). Most 238 
frequently these activities were organized by national PEN societies as local trainings (17 239 
countries [85%]), quite common were also postgraduate trainings and ESPEN LLL programs 240 
(16 [80%] and 12 [60%] countries respectively). Investigation of the relationship between 241 
different types of medical training and the average per capita healthcare expenditure showed 242 
little linkage with postgraduate, ESPEN LLL or local PEN society training. The prevalence of 243 
undergraduate training was clearly related to the country's health care expenditure showing a 244 
significant increase across categories of financial commitment (p=0.042) (Table 6). 245 
No relation between the number of educational activities and the factual use of CN was 246 
observed. (p>0.05) 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
DISCUSSION 256 
Malnutrition represent a serious health care thread as it increases morbidity, mortality and 257 
health care cost for all age groups. [1,2]  A new Croatian study showed that the total cost of 258 
adult malnutrition for selected diagnoses was €97.35 million per year, accounting for 3.38% 259 
of the total Croatian national health care budget, and the average cost per patient was 260 
estimated at €1640.48. [12] The largest share was used for medications (43%), followed by 261 
34% for hospitalization, 13% for community health nursing, while PN and EN costs 262 
contributed with 6% and 1% respectively.[12] Malnutrition is widespread - recent European 263 
survey showed that 57.4% of Estonian, 39.4% of Turkish, 32.8% Greek, 21.9% Polish and 264 
14.2% of Lithuanian patients were diagnosed with malnutrition [13] Moreover, severe 265 
malnutrition was reported in 19.7% of Turkish patients, and in 9.9% of Polish and Greek 266 
individuals (9.4%).[13]  267 
Therefore, actions like FAM, are of the utmost importance. The implementation of EN and 268 
PN, which are, along with screening, key elements for the efficient FAM, vary among 269 
countries. The same study showed that they could be influenced by the political situation, 270 
economy as well as the activity of the national PEN societies in term of raising the awareness, 271 
education, cooperation with funding and policy-making authorities. The latter seemed to be 272 
affected by the economy as well. 273 
The factual associations among education, economy, reimbursement and the utilization of EN 274 
and PN have, however, never been thoroughly analyzed. Therefore, the following study was 275 
supposed to address those ambiguities.  276 
Some of results were really encouraging: both EN and PN are used in all of the European 277 
countries surveyed, apparently independently of the income of the country. They are, 278 
however, mostly available to patients at hospital settings, and often unavailable to those at 279 
chronic care facilities or at home. National income did not appear to influence that situation 280 
directly, but greatly influenced reimbursement both for EN and PN, which seem to have 281 
important effects on their utilization.  Oral nutritional supplements (ONS) were the only 282 
treatment method to prove otherwise. Education for clinical nutrition was present in all 283 
participating countries (100%). Those included, however, mostly postgraduate activities, often 284 
held by the national PEN or ESPEN, not by the local institutions.  Pregraduate education was 285 
much less frequent, and that fact was inversely related to country income. The level of 286 
education did not influence the administration of neither EN nor PN.  287 
To our knowledge this is the first survey on the educational and economic aspects of the fight 288 
against malnutrition. Authors are aware of the limitations of the study, particularly the 289 
dependence on local PEN’s representatives regarding the provision of data. It is important, 290 
however, to emphasize that there is no other method of collecting such circuitous data. 291 
Undoubtedly, the study offered a lot of new data, which provided a new insight into the 292 
treatment of malnutrition.  293 
Results indicated unequivocally that economic situation influences all aspects of actions 294 
against malnutrition, including education and treatment. The reimbursement for EN and PN 295 
seemed also to be of a vital role for those activities. 296 
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ANSWERS TO EDITOR AND REVIEWER’s COMMENTS 
MS. Ref. No.:  YCLNU-D-15-00488 
Title: "Economy matters to Fight Against Malnutrition: results from a multicenter survey" 
 
Comment: 
For this article the authors did some changes which are acceptable. 
However in the Introduction it is imperative to mention that ONCA is an action driven by 
ENHA -an association of stakeholders in which ESPEN is a Key player 
 
Answer: The text was changed – see below. 
‘In 2014 FAM became a part of a campaign called Optimal Nutrition Care for All 
(ONCA).[10] ONCA’s aim is to facilitate greater screening for risk of disease-related 
malnutrition/undernutrition and nutritional care implementation across Europe.[10] It 
includes, among others, the worldwide ‘NutritionDay’ survey, many local and international 
events (including ONCA conferences in Brussels, Prague, Vienna, Warsaw and Zagreb), 
scientific and research grants, scientific and educational symposia, workshops and trainings. 
This activity is govern by European Nutrition for Health Alliance (ENHS), an association of 
stakeholders, in which ESPEN is the key player. Therefore, actions could be performed in a 
close cooperation with national scientific societies for enteral and parenteral nutrition (or 
clinical nutrition) societies, so-called ‘PEN’ societies.’ 
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